These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5126159)

  • 1. [Resistance of AKR mice to the oncogenic action of Moloney murine sarcoma virus].
    Tsysina EN; Irlin IS
    Biull Eksp Biol Med; 1971 Oct; 72(10):85-8. PubMed ID: 5126159
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 4. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in mice infected neonatally with Moloney leukaemogenic and murine sarcoma viruses.
    Hirsch MS; Allison AC; Harvey JJ
    Nature; 1969 Aug; 223(5207):739-40. PubMed ID: 4308421
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunodepression by oncogenic viruses.
    Dent PB
    Prog Med Virol; 1972; 14():1-35. PubMed ID: 4338188
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative and qualitative study of myeloid chloroleukemia virus based on the resistance phenomenon.
    Prigozhina EL; Stavrovskaya AA
    Fed Proc Transl Suppl; 1965; 24(5):929-32. PubMed ID: 4284566
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice.
    Biasi G; Saggin L; Dazzi F; Collavo D
    Transplant Proc; 1983 Dec; 15(4):2125-7. PubMed ID: 6608813
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody formation, latency and leukemia: infection with Moloney virus.
    Cremer NE; Taylor DO; Hagens SJ
    J Immunol; 1966 Mar; 96(3):495-508. PubMed ID: 5932581
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.
    Cianciolo GJ; Matthews TJ; Bolognesi DP; Snyderman R
    J Immunol; 1980 Jun; 124(6):2900-5. PubMed ID: 6246170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective immunoglobulin deficiencies in rats infected with Moloney virus.
    Cremer NE
    J Immunol; 1967 Jul; 99(1):71-81. PubMed ID: 4166025
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection by immune spleen cells against challenge with Moloney sarcoma virus. Effect of stage of donor response.
    Pollack S; Nelson K
    Transplantation; 1973 May; 15(5):510-3. PubMed ID: 4710486
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of interferon in the protective effect of the double-stranded polyribonucleotide against murine tumors induced by Moloney sarcoma virus.
    De Clercq E; De Somer P
    J Natl Cancer Inst; 1971 Dec; 47(6):1345-55. PubMed ID: 5120413
    [No Abstract]   [Full Text] [Related]  

  • 18. Rat virus-mediated suppression of leukemia induction by Moloney virus in rats.
    Bergs VV
    Cancer Res; 1969 Sep; 29(9):1669-72. PubMed ID: 5822476
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transformation in a rat fibroblast culture caused by the Moloney virus].
    Kukaĭn RA; Berzinia ME; Nagaeva LI; Nitavskaia SD
    Vopr Onkol; 1972; 18(4):63-6. PubMed ID: 4555015
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunofluorescence and virus recovery: correlation in a murine leukemia system.
    Orr HC; Moloney JB; Reisher JI; Bushar HF
    Cancer Res; 1968 Sep; 28(9):1793-6. PubMed ID: 4877739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.